AGEN

Agenus Inc. - Common Stock (AGEN)

About Agenus Inc. - Common Stock (AGEN)

Agenus, Inc. is a clinical-stage company, which engages in the development and commercialization of technologies to treat cancers and infectious diseases. Its product pipeline includes Balstilimab, Zalifrelimab, AGEN1181, AGEN1327, AGEN2373, AGENt-797 and AGEN1777. The company was founded by Garo H. Armen and Pramod K. Srivastava on March 31, 1994 and is headquartered in Lexington, MA.

Details

Daily high

$8.18

Daily low

$7.42

Price at open

$8.14

52 Week High

$8.85

52 Week Low

$2.71

Market cap

371.0M

Dividend yield

Volume

1.2M

Avg. volume

1.1M

P/E ratio

3.11

Agenus Inc. - Common Stock News